hHLA-DPA1*03: 01

Nomenclature

C57BL/6Smoc-H2-Aatm1(hHLA-DPA1*03: 01)Smoc

Cat. NO.

NM-HU-210009

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
H2-Aa

Model Description

The endogenous mice H2-Aa gene was replaced by human HLA-DPA1*03: 01 gene
Research Application:inmmue therapy;drug screening

Validation Data

image.png

Fig.1 Detection of HLA-DPA1 expression in large Intestine by RT-PCR. Wild type:  one band at 429 bp with primers F1/R1 (mHla-dpa1); Homozygous: one band at 256 bp with primers F2/R2 (hHLA-DPA1). Abbr. M, DNA marker; HO, homozygous; WT, wild type.

image.png

Fig2. Expression characterization of hHLA-DP on human PBMC.

image.png

Fig3. Expression characterization of HLA-DPA1*03:01 on DCs in Blood in HLA-DPA1*03:01 KI mice. Note: The anti-hMHC II antibody has been reported to react with a shared epitope of HLA-DR, HLA-DP, and HLA-DQ. The anti-mMHC II antibody reacts with a polymorphic determinant shared by the I-Ab, I-Ad, I-Aq, I-Ed, and I-Ek MHC class II alloantigens from mice carrying H-2p,r,q,b,d,u haplotypes.


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more